CAR T cells targeting MMP2

Chimeric antigen receptor T-cell therapy targeting MMP2 · Chimeric Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAR T cells targeting MMP2, covering 2026-01-29 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma [Phase 1]